Home
>
National Drug Code (NDC)
>
TAVIST
TAVIST - 0067-1190-16 - (Clemastine fumarate)
Drug Information of TAVIST
| Product NDC: | 0067-1190 |
| Proprietary Name: | TAVIST |
| Non Proprietary Name: | Clemastine fumarate |
| Active Ingredient(s): | 1.34 mg/1 & nbsp; Clemastine fumarate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TAVIST
| Product NDC: | 0067-1190 |
| Labeler Name: | Novartis Consumer Health, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | NDA020925 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100101 |
Package Information of TAVIST
| Package NDC: | 0067-1190-16 |
| Package Description: | 2 BLISTER PACK in 1 CARTON (0067-1190-16) > 16 TABLET in 1 BLISTER PACK |
NDC Information of TAVIST
| NDC Code | 0067-1190-16 |
| Proprietary Name | TAVIST |
| Package Description | 2 BLISTER PACK in 1 CARTON (0067-1190-16) > 16 TABLET in 1 BLISTER PACK |
| Product NDC | 0067-1190 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Clemastine fumarate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100101 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Consumer Health, Inc. |
| Substance Name | CLEMASTINE FUMARATE |
| Strength Number | 1.34 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
